Composition
- Active ingredients
- LENVATINIB MESYLATE 10MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LENVATINIB MESYLATE 10MG · CapsuleThis page
- LENVATINIB MESYLATE 4MG · CapsuleANDA213092-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA213092.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lenvatinib
- Active substance
- lenvatinib mesylate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Sun Pharm Inds Inc
- Status
- Prescription
- FDA approval
- 1 Mar 2022
- Application
- ANDA213092-002